This is because we had to closely match the ancestry of the study samples with those of the control samples from the UK Biobank, which were largely of European ancestry. This was to be sure that the differences we are identifying are more likely to be because of ME/CFS, and not because of differences in ancestry. An ongoing analysis uses all study samples from all ancestries.